Methods: Thoracic aortas removed from 10-week-old male Sprague-Da

Methods: Thoracic aortas removed from 10-week-old male Sprague-Dawley rats were cut into 3- to 5-mm rings and were cultured for 10 days. Phosphate concentration was titrated in the medium to induce vascular calcification. Ferric citrate was applied as an iron donor with different concentrations. To study the preventive effects, 0.1 mM iron was introduced since 2 days before, on the same time and on the 3th or 6th day in

high phosphate treated aorta until 10th day. Calcification was assessed by Alizarin red staining and the calcium content of aorta was determined by the o-cresolphthalein complex-one method. Results: Vascular calcification was observed in rat aortas which were cultured in a high-phosphate medium. Calcium deposition was dramatically decreased by co-incubation with elevated MAPK Inhibitor Library iron (0.1 mM) compared with normal iron in medium (2.00 ± 2.32 vs 40.73 ± 17.25 mg/g, p < 0.01). Calcification Roxadustat cost was significantly prevented if high iron level was introduced before (0.53 ± 0.39 mg/g, p < 0.01) or on the same time (7.38 ± 8.62 mg/g, p < 0.05) when high phosphate level was achieved. The inhibitory effect of iron was not significant after 3 or 6 days exposure to high phosphate concentration. Conclusions: Iron significantly reduced and prevented high phosphate-induced calcification in rat aorta. The inhibitory effect was no longer exit if aortic calcification

had already established. The mechanism(s) for the effects of iron on vascular calcification needed to be explored. FUJII HIDEKI, NAKAI KENTARO, GOTO SHUNSUKE, NISHI SHINICHI Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine Introduction: Clinical features at hemodialysis initiation affect the prognosis during the subsequent dialysis period, while they were not fully elucidated in very elderly patients. The purpose of this study was to clarify clinical features associated with chronic kidney disease- mineral bone disorder (CKD-MBD) and cardiovascular disease (CVD) at hemodialysis initiation in these

patients. Methods: Twenty consecutive elderly patients with end stage renal disease Mirabegron (ESRD) (≧80 years; VE group) and 35 consecutive control patients with ESRD Results: Diastolic blood pressure and pulse pressure were significantly higher in the VE group than in the control group. Though cardiac function was comparable between the two groups, left ventricular mass index tended to be greater in the control group. Though serum creatinine levels were significantly lower in the VE group, estimated glomerular filtration rate was comparable between the two groups. In addition, despite lower serum phosphate levels and calcium-phosphate products, TAC, AVC and MAC were more severe in the VE group compared to the control group. In the VE group, 12 patients had been followed up by nephrologists (F group) and 8 had not (NF group).

This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>